Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

Exciting potential in Korro Bio, Inc.'s non-viral gene editing platform as they enter clinical trials with a strong cash ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

In 2024, we’ve witnessed some incredible advancements in medicine, from gene editing to stem cell therapies. These ...

A new gene editing tool that helps cellular machinery skip parts of genes responsible for diseases has been applied to reduce ...

After hours: December 26 at 4:20:00 PM EST Loading Chart for RNA ...

The goal is to democratize RNA technology,” said one of the professors behind the project, known as BioFoundry.

Across 2024, more than 4,940 workers lost their jobs at Massachusetts life sciences companies. The Business Journal has a ...

Ranging from technology and biotechnology to computer science, programming, medicine, energy, and the environment ...

WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat ...

The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and ...

CoV-2, the virus that causes Covid-19 disease, first emerged in China’s Wuhan, the evidence so far makes a convincing case ...